Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
Ovarian Cancer Community
This patient support community is for discussions relating to ovarian cancer, biopsy, chemotherapy, clinical trials, genetics, hysterectomy, immunotherapy, radiation therapy, screening, and staging.
OVCA and Breast Cancer
by Jen Y, Dec 05, 2007 04:12PM
Hello, Dr. Goodman. A few months ago, I wrote in about my mother (age 63, diagnosed 3C in Oct 2005, Doxil/Carbo as a second line treatment) who was on tamoxifen during a chemo break. One month into taking the tamoxifen, her CA-125 began to rise, and she switched Gemzar/Carbo. She has recently undergone surgery for breast cancer. She is being treated in Taiwan and has not been genetically tested. Does the potential presence of a BRCA mutation make her disease more susceptible to certain treatments, i.e. aromatase inhibitors or certain chemos? Thanks.
Member Comments (1)
by Jen Y, Dec 05, 2007 04:18PM
oops...I will repost to the medical forum.
Post Comment
